Althea Cannabis Medicine Approved For Reimbursement In Ireland

Australia’s Althea Group Holdings Limited (ASX:AGH) has announced another of its cannabis medicines has been approved for patient reimbursement in Ireland. Althea states the Republic of Ireland’s Primary Care Reimbursement Service has approved the company’s THC20:CBD1 formulation, making it free of charge for Irish patients being treated for CINV – chemotherapy-induced nausea and vomiting. The company […]

Go to Source

Powered by WPeMatico